TwentyTwentyTweets
-
Join 7,195 other subscribers
-
Recent Posts
Pages
Tag Archives: biotechnology
The ups and downs of stem cell research
Guest blog by Sean Summers, Research Intern at 2020health A biotechnology firm recently announced positive results from a clinical trial on stem cell therapy for disabled stroke patients. The results of this trial lead by Professor Keith Muir, Principle Investigator … Continue reading
Guest Blogspot – The UK Needs More Biotechnology Companies
The success of US biotechnology companies contrasts sharply with the disappointment in other countries. British companies valued by stock markets at more than about US $ 4 billion go in the FTSE 100 index. There are no biotechnology companies big … Continue reading
Posted in Business, Drugs, Emerging technologies, Finance, Genetics, Pharma, Policy, Research, Technology
Tagged 2020health, Amgen, biotechnology, biotechnology company, block-buster, blockbuster, BTG, drug pricing, Genentech, genetics, medicine, Nobel Prize, patent box, pharmaceutical, pricing, R&D, R&D tax credit, Research, value-based, value-based pricing
1 Comment
Guest Blogspote: How to encourage pharmaceutical R&D
Politicians should only attempt the possible. We must recognise what we cannot do. The UK Government alone cannot influence the direction of R&D significantly. The sums of money involved are so vast that R&D only makes sense in a global … Continue reading
Posted in Andrew Lansley, Business, competition, Department of Health, Drugs, Health Bill, Hospitals, Innovation, NHS, Pharma, Policy, Research, Uncategorized, White Paper
Tagged 2020health, Andrew lansley, biotechnology, breakthrough, Clinical trials, competition, Department of Health, Equity and Excellence, health, Health Bill, medicine, National Health Service, NHS, NICE, patent box, Pfizer, pharmaceutical, pricing, R&D, R&D tax credit, Research, university, value-based, value-based pricing, wholesaler
Leave a comment